A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys
Clinical Infectious Diseases · 2024
DOI: 10.1093/cid/ciae211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Nora E Rosenberg und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Hauptthemen laut MEDLINE: HIV Infections, HIV-1, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cepheid, NIAID NIH HHS, FHERA.
Abstract (Originalsprache)
Background
Women in Africa disproportionately acquire human immunodeficiency virus type 1 (HIV-1). Understanding which women are most likely to acquire HIV-1 can guide focused prevention with preexposure prophylaxis (PrEP). Our objective was to identify women at the highest risk of HIV-1 and estimate PrEP efficiency at different sensitivity levels.
Methods
Nationally representative data were collected from 2015 through 2019 from 15 population-based household surveys. This analysis included women aged 15–49 who tested HIV-1 seronegative or had recent HIV-1. Least absolute shrinkage and selection operator regression models were fit with 28 variables to predict recent HIV-1. Models were trained on the full population and internally cross-validated. Performance was evaluated using area under the receiver operating characteristic curve (AUC), sensitivity, and number needed to treat (NNT) with PrEP to avert 1 infection.
Results
Among 209 012 participants, 248 had recent HIV-1 infection, representing 118 million women and 402 000 (95% confidence interval [CI], 309 000–495 000) annual infections. Two variables were retained: living in a subnational area with high HIV-1 viremia and having a sexual partner living outside the home. The full-population AUC was 0.80 (95% CI, .76–.84); cross-validated AUC was 0.79 (95% CI, .75–.84). At 33% sensitivity, 130 000 cases could be averted if 7.9 million women were perfectly adherent to PrEP; NNT would be 61. At 67% sensitivity, 260 000 cases could be averted if 25.1 million women were perfectly adherent; NNT would be 96.
Conclusions
This risk assessment tool was generalizable, predictive, and parsimonious with trade-offs between reach and efficiency.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Behavior, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
- Child and Adolescent Health Unit, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe.
- University of Zimbabwe Clinical Trials Research Centre, University of Zimbabwe, Harare, Zimbabwe.
- Division of General Internal Medicine, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
- Global Pediatrics Program and Division of Infectious Diseases, Department of Pediatrics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
ORCID-Profile: Nora E Rosenberg, Bonnie E Shook-Sa, Yating Zou, Lynda Stranix-Chibanda, Marcel Yotebieng, Wilbroad Mutale, Linda-Gail Bekker, Manhattan E Charurat, Sizulu Moyo, Khangelani Zuma, Jessica Justman, Michael G Hudgens, Benjamin H Chi
Förderung
- Cepheid
- NIAID NIH HHS
- FHERA
- NIMH NIH HHS
- Novartis
- FIC NIH HHS
- CGH CDC HHS
- NHLBI NIH HHS
Zitieren
APA
Rosenberg, N. E., Shook-Sa, B. E., Young, A. M., Zou, Y., Stranix-Chibanda, L., Yotebieng, M., Sam-Agudu, N. A., Phiri, S. J., Mutale, W., Bekker, L. G., Charurat, M. E., Moyo, S., Zuma, K., Justman, J., Hudgens, M. G., & Chi, B. H. (2024). A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae211
Vancouver
Rosenberg NE, Shook-Sa BE, Young AM, Zou Y, Stranix-Chibanda L, Yotebieng M, et al. A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae211
BibTeX
@article{Rosenberg2024,
author = {Rosenberg, Nora E and Shook-Sa, Bonnie E and Young, Amber M and Zou, Yating and Stranix-Chibanda, Lynda and Yotebieng, Marcel and Sam-Agudu, Nadia A and Phiri, Sam J and Mutale, Wilbroad and Bekker, Linda-Gail and Charurat, Manhattan E and Moyo, Sizulu and Zuma, Khangelani and Justman, Jessica and Hudgens, Michael G and Chi, Benjamin H},
title = {A Human Immunodeficiency Virus Type 1 Risk Assessment Tool for Women Aged 15–49 Years in African Countries: A Pooled Analysis Across 15 Nationally Representative Surveys},
journal = {Clinical Infectious Diseases},
year = {2024},
doi = {10.1093/cid/ciae211}
}
EUVIMED